BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31302815)

  • 41. The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway.
    Schmitt-Ney M; Camussi G
    PLoS One; 2015; 10(3):e0121474. PubMed ID: 25806826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tim-3 expression in cervical cancer promotes tumor metastasis.
    Cao Y; Zhou X; Huang X; Li Q; Gao L; Jiang L; Huang M; Zhou J
    PLoS One; 2013; 8(1):e53834. PubMed ID: 23335978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.
    Deel MD; Slemmons KK; Hinson AR; Genadry KC; Burgess BA; Crose LES; Kuprasertkul N; Oristian KM; Bentley RC; Linardic CM
    Clin Cancer Res; 2018 Jun; 24(11):2616-2630. PubMed ID: 29514840
    [No Abstract]   [Full Text] [Related]  

  • 45. Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1.
    Wang Z; Ji G; Wu Q; Feng S; Zhao Y; Cao Z; Tao C
    Life Sci; 2018 Oct; 210():263-270. PubMed ID: 30138596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer.
    Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P
    Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Forkhead box O-class 1 and forkhead box G1 as prognostic markers for bladder cancer.
    Kim TH; Jo SW; Lee YS; Kim YJ; Lee SC; Kim WJ; Yun SJ
    J Korean Med Sci; 2009 Jun; 24(3):468-73. PubMed ID: 19543511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.
    Roeb W; Boyer A; Cavenee WK; Arden KC
    Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18085-90. PubMed ID: 17986608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guilt by association: PAX3-FOXO1 regulates gene expression through selective destabilization of the EGR1 transcription factor.
    Roeb W; Boyer A; Cavenee WK; Arden KC
    Cell Cycle; 2008 Apr; 7(7):837-41. PubMed ID: 18414034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
    Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
    Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An extensive analysis of the prognostic and immune role of FOXO1 in various types of cancer.
    Li J; Wang C; Xu X; Chen J; Guo H
    Braz J Med Biol Res; 2024; 57():e13378. PubMed ID: 38716982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
    Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
    J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.
    Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
    J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Roles and Regulatory Mechanisms of Tight Junction Protein Cingulin and Transcription Factor Forkhead Box Protein O1 in Human Lung Adenocarcinoma A549 Cells and Normal Lung Epithelial Cells.
    Ishii D; Shindo Y; Arai W; Konno T; Kohno T; Honda K; Miyajima M; Watanabe A; Kojima T
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Evaluation of FOXO1 as a Tumor Suppressor in Prostate Cancer.
    Yang N; Wu J; Zhang T; Yang F; Shao J; He C; Qin L
    Comput Math Methods Med; 2021; 2021():8773423. PubMed ID: 34552661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
    Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity.
    Andreasen S; Bishop JA; Hellquist H; Hunt J; Kiss K; Rinaldo A; Skálová A; Willems SM; Williams M; Ferlito A
    Virchows Arch; 2018 Nov; 473(5):615-626. PubMed ID: 30109475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.
    Wang J; Wang Y; Wang J; Zhang S; Yu Z; Zheng K; Fu Z; Wang C; Huang W; Chen J
    Bioengineered; 2022 May; 13(5):13970-13985. PubMed ID: 35723050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer.
    Fan Y; Nan Y; Huang J; Zhong H; Zhou W
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29720427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.